CompletedNot Applicable

Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.

United States369 participantsStarted 2016-10

Plain-language summary

This is a retrospective-prospective study design. Patients who completed treatment approximately 3 years (range of 2-4 years) at time of IRB approval of this study will be identified and any existing data in the patient's record will be collected in addition to conducting office visits for long-term follow-up.

Who can participate

Age range41 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Previously completed treatment for non-melanoma skin cancer using Xoft eBx Electronic Brachytherapy System or Mohs surgery;
✓. Provides informed Consent;
✓. Greater than 40 years of age;
✓. Pathological diagnosis confirmed to be squamous cell or basal cell carcinoma prior to treatment;
✓. Cancer Staging included in this study:

Exclusion criteria

✕. Target area is adjacent to a burn scar
✕. Any prior definitive surgical resection of the cancer, prior to Radiation Treatment
✕. Known perineural invasion
✕. Actinic Keratosis
✕. Known spread to regional lymph nodes
✕. Known metastatic disease

What they're measuring

Absence of Local Recurrence at Treatment Site(s) Greater or Equal to 3 Years Follow-up

Timeframe: Range greater or equal to 3 years post last Xoft eBx or MMS treatment at the time of study start at1 long-term prospective visit by study completion.

Trial details

NCT IDNCT03024866

SponsorXoft, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2017-03

Results submitted2018-03-20

View on ClinicalTrials.gov More Nonmelanoma Skin Cancer trials